|

SHR-A2009 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • Fudan University2

Indications

  • HER2-negative Breast Cancer2
  • Advanced Breast Cancer2
  • Breast Cancer2
  • Cancer2
  • Hormone Receptor Positive Tumor1

Other2 trials

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
Phase 2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.